Log in

NYSEAMERICAN:VNRXVolitionRX Stock Price, Forecast & News

$3.29
+0.06 (+1.86 %)
(As of 08/3/2020 04:00 PM ET)
Add
Compare
Today's Range
$3.19
Now: $3.29
$3.31
50-Day Range N/A
52-Week Range
$2.22
Now: $3.29
$6.84
Volume249,664 shs
Average Volume357,207 shs
Market Capitalization$135.56 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
VolitionRX Limited, a life sciences company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. The company develops blood-based Nu.Q immunoassays to detect specific biomarkers. VolitionRX Limited is based in Singapore.
Read More
VolitionRX logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 3.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.82 out of 5 stars


Industry, Sector and Symbol

Stock Exchange NYSEAMERICAN
Industry Medical Laboratories & Research
Sub-IndustryN/A
SectorMedical
Current SymbolNYSEAMERICAN:VNRX
Previous SymbolNYSEMKT:VNRX
CUSIPN/A
CIKN/A
Phone646 650 1351

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees44
Market Cap$135.56 million
Next Earnings Date8/10/2020 (Estimated)
OptionableNot Optionable
$3.29
+0.06 (+1.86 %)
(As of 08/3/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive VNRX News and Ratings via Email

Sign-up to receive the latest news and ratings for VNRX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











VolitionRX (NYSEAMERICAN:VNRX) Frequently Asked Questions

Do Wall Street analysts recommend investors buy shares of VolitionRX?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for VolitionRX in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for VolitionRX
.

When is VolitionRX's next earnings date?

VolitionRX is scheduled to release its next quarterly earnings announcement on Monday, August 10th 2020.
View our earnings forecast for VolitionRX
.

How were VolitionRX's earnings last quarter?

VolitionRX Ltd (NYSEAMERICAN:VNRX) issued its quarterly earnings results on Thursday, May, 7th. The medical research company reported ($0.14) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.10) by $0.04. The medical research company had revenue of $0.54 million for the quarter.
View VolitionRX's earnings history
.

What price target have analysts set for VNRX?

3 analysts have issued 1-year price objectives for VolitionRX's stock. Their forecasts range from $7.00 to $10.00. On average, they anticipate VolitionRX's stock price to reach $8.33 in the next twelve months. This suggests a possible upside of 153.3% from the stock's current price.
View analysts' price targets for VolitionRX
.

Has VolitionRX been receiving favorable news coverage?

Press coverage about VNRX stock has trended somewhat positive recently, according to InfoTrie. The research group identifies negative and positive press coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. VolitionRX earned a news sentiment score of 1.8 on InfoTrie's scale. They also gave media headlines about the medical research company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the near term.
View the latest news about VolitionRX
.

Are investors shorting VolitionRX?

VolitionRX saw a increase in short interest in the month of June. As of June 30th, there was short interest totaling 544,700 shares, an increase of 26.3% from the June 15th total of 431,200 shares. Based on an average daily volume of 299,600 shares, the short-interest ratio is presently 1.8 days. Approximately 2.0% of the shares of the company are sold short.
View VolitionRX's Current Options Chain
.

Who are some of VolitionRX's key competitors?

What other stocks do shareholders of VolitionRX own?

Based on aggregate information from My MarketBeat watchlists, some companies that other VolitionRX investors own include (CHK), Bausch Health Companies (BHC), Verastem (VSTM), Bausch Health Companies (BHC), Ring Energy (REI), Ring Energy (REI), Crispr Therapeutics (CRSP), Exelixis (EXEL), Gilead Sciences (GILD) and ContraFect (CFRX).

Who are VolitionRX's key executives?

VolitionRX's management team includes the following people:
  • Dr. Martin Charles Faulkes, Exec. Chairman (Age 75)
  • Mr. Cameron Reynolds, Founder, CEO, Pres & Director (Age 48)
  • Dr. Jacob Vincent Micallef Ph.D., MBA, Chief Scientific Officer (Age 63)
  • Dr. Jason Bradley Terrell, Chief Medical Officer (Age 39)
  • Mr. Rodney Gerard Rootsaert LLB, Corp. Sec. (Age 48)

What is VolitionRX's stock symbol?

VolitionRX trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "VNRX."

Who are VolitionRX's major shareholders?

VolitionRX's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include UBS Group AG (0.03%). Company insiders that own VolitionRX stock include Cameron John Reynolds, Corp Ltd Eight, Guy Archibald Innes and Martin Charles Faulkes.
View institutional ownership trends for VolitionRX
.

Which major investors are buying VolitionRX stock?

VNRX stock was bought by a variety of institutional investors in the last quarter, including UBS Group AG. Company insiders that have bought VolitionRX stock in the last two years include Cameron John Reynolds, Corp Ltd Eight, Guy Archibald Innes, and Martin Charles Faulkes.
View insider buying and selling activity for VolitionRX
.

How do I buy shares of VolitionRX?

Shares of VNRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is VolitionRX's stock price today?

One share of VNRX stock can currently be purchased for approximately $3.29.

How big of a company is VolitionRX?

VolitionRX has a market capitalization of $135.56 million. VolitionRX employs 44 workers across the globe.

What is VolitionRX's official website?

The official website for VolitionRX is www.volitionrx.com.

How can I contact VolitionRX?

The medical research company can be reached via phone at 646 650 1351.

This page was last updated on 8/4/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.